Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „showed“
Suchtreffer
Begriffe & Kennungen
Abilify Maintena · 4.8 · Data from an open-label study of patients treated with Abilify Maintena 960 mg, showed minimal change from bas
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · Riociguat Preclinical studies showed an additive systemic blood pressure lowering effect when PDE5 inhibitors
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · Riociguat Preclinical trials showed an additive systemic blood pressure lowering effect when PDE5 inhibitors w
Eintrag öffnenAdempas · 4.5 · 30 PDE5 inhibitors Preclinical studies in animal models showed additive systemic blood pressure lowering effec
Eintrag öffnenAdempas · 4.5 · PDE5 inhibitors Preclinical studies in animal models showed additive systemic blood pressure lowering effect w
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · In vitro studies in rat hepatocytes also showed that ambrisentan did not induce Pgp, BSEP or MRP2 protein expr
Eintrag öffnenApixaban Accord · 4.5 · 44 Effect of apixaban on other medicinal products In vitro apixaban studies showed no inhibitory effect on the
Eintrag öffnenApixaban Accord · 4.5 · Effect of apixaban on other medicinal products In vitro apixaban studies showed no inhibitory effect on the ac
Eintrag öffnenAvastin · 4.8 · Most patients who developed CHF during mBC trials showed improved symptoms and/or left ventricular function fo
Eintrag öffnenAzilect · 4.5 · In vitro studies showed that rasagiline at a concentration of 1 µg/ml (equivalent to a level that is 160 times
Eintrag öffnenBesremi · 4.5 · Co-administration of pegylated interferon alfa-2b showed no significant interaction with tolbutamide 9 -acetyl
Eintrag öffnenBrilique · 4.5 · Others Clinical pharmacology interaction studies showed that co-administration of ticagrelor with heparin, eno
Eintrag öffnenBrilique · 4.5 · Others Clinical pharmacology interaction studies showed that co-administration of ticagrelor with heparin, eno
Eintrag öffnenBrilique · 4.5 · Others Clinical pharmacology interaction studies showed that co-administration of ticagrelor with heparin, eno
Eintrag öffnenBuccolam · 4.5 · Atorvastatin showed a 1.4-fold increase in plasma concentrations of intravenous midazolam compared to control
Eintrag öffnenCialis · 4.5 · Riociguat Preclinical studies showed an additive systemic blood pressure lowering effect when PDE5 inhibitors
Eintrag öffnenCialis · 4.5 · Riociguat Preclinical studies showed an additive systemic blood pressure lowering effect when PDE5 inhibitors
Eintrag öffnenCialis · 4.5 · Riociguat Preclinical studies showed an additive systemic blood pressure lowering effect when PDE5 inhibitors
Eintrag öffnenConstella · 4.5 · A food interaction clinical study in healthy subjects showed that linaclotide was not detectable in plasma eit
Eintrag öffnenCotellic · 4.5 · A clinical drug-drug interaction (DDI) study in cancer patients showed that plasma concentrations of midazolam
Eintrag öffnen